434 related articles for article (PubMed ID: 19551554)
21. [Voice disorders in asthma].
Hackenberg S; Hacki T; Hagen R; Kleinsasser NH
Laryngorhinootologie; 2010 Aug; 89(8):460-4. PubMed ID: 20714971
[TBL] [Abstract][Full Text] [Related]
22. The Utility of the Reflux Symptom Index for Diagnosis of Laryngopharyngeal Reflux in an Allergy Patient Population.
Brauer DL; Tse KY; Lin JC; Schatz MX; Simon RA
J Allergy Clin Immunol Pract; 2018; 6(1):132-138.e1. PubMed ID: 28606786
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders.
Koufman JA; Amin MR; Panetti M
Otolaryngol Head Neck Surg; 2000 Oct; 123(4):385-8. PubMed ID: 11020172
[TBL] [Abstract][Full Text] [Related]
24. Voice disorders in the general Greek population and in patients with laryngopharyngeal reflux. Prevalence and risk factors.
Spantideas N; Drosou E; Karatsis A; Assimakopoulos D
J Voice; 2015 May; 29(3):389.e27-32. PubMed ID: 25795358
[TBL] [Abstract][Full Text] [Related]
25. Laryngopharyngeal reflux: a prospective analysis of a 34 item symptom questionnaire.
Papakonstantinou L; Leslie P; Gray J; Chadwick T; Hudson M; Wilson JA
Clin Otolaryngol; 2009 Oct; 34(5):455-9. PubMed ID: 19793278
[TBL] [Abstract][Full Text] [Related]
26. Perceptual, Aerodynamic, and Acoustic Characteristics of Voice Changes in Patients with Laryngopharyngeal Reflux Disease.
Lechien JR; Khalife M; Huet K; Finck C; Bousard L; Delvaux V; Piccaluga M; Harmegnies B; Saussez S
Ear Nose Throat J; 2019 Jul; 98(6):E44-E50. PubMed ID: 30961379
[TBL] [Abstract][Full Text] [Related]
27. Incidence of underlying laryngeal pathology in patients initially diagnosed with laryngopharyngeal reflux.
Rafii B; Taliercio S; Achlatis S; Ruiz R; Amin MR; Branski RC
Laryngoscope; 2014 Jun; 124(6):1420-4. PubMed ID: 24155128
[TBL] [Abstract][Full Text] [Related]
28. Otolaryngologic manifestations of gastro-oesophageal reflux disease in Lagos.
Somefun OA; Wanda CB; Adesanya AA; Thomas MO; Esan OO
Niger Postgrad Med J; 2006 Sep; 13(3):225-9. PubMed ID: 17066111
[TBL] [Abstract][Full Text] [Related]
29. Impact of laryngopharyngeal reflux on subjective and objective voice assessments: a prospective study.
Lechien JR; Huet K; Khalife M; Fourneau AF; Delvaux V; Piccaluga M; Harmegnies B; Saussez S
J Otolaryngol Head Neck Surg; 2016 Nov; 45(1):59. PubMed ID: 27825368
[TBL] [Abstract][Full Text] [Related]
30. Gastro-oesophageal reflux disease in chronic laryngitis: prevalence and response to acid-suppressive therapy.
Qua CS; Wong CH; Gopala K; Goh KL
Aliment Pharmacol Ther; 2007 Feb; 25(3):287-95. PubMed ID: 17269990
[TBL] [Abstract][Full Text] [Related]
31. The role of psychological distress in laryngopharyngeal reflux patients: a prospective questionnaire study.
Shin KS; Tae K; Jeong JH; Jeong SW; Kim KR; Park CW; Park YC
Clin Otolaryngol; 2010 Feb; 35(1):25-30. PubMed ID: 20447159
[TBL] [Abstract][Full Text] [Related]
32. Acoustic analysis findings in objective laryngopharyngeal reflux patients.
Oguz H; Tarhan E; Korkmaz M; Yilmaz U; Safak MA; Demirci M; Ozluoglu LN
J Voice; 2007 Mar; 21(2):203-10. PubMed ID: 16406737
[TBL] [Abstract][Full Text] [Related]
33. Gender differences in the presentation of dysphonia related to laryngopharyngeal reflux disease: a case-control study.
Lechien JR; Huet K; Khalife M; Fourneau AF; Finck C; Delvaux V; Piccaluga M; Harmegnies B; Saussez S
Eur Arch Otorhinolaryngol; 2018 Jun; 275(6):1513-1524. PubMed ID: 29582172
[TBL] [Abstract][Full Text] [Related]
34. Vocal Tract Discomfort and Dysphonia in Patients Undergoing Empiric Therapeutic Trial with Proton Pump Inhibitor for Suspected Laryngopharyngeal Reflux.
Mozzanica F; Robotti C; Lechien JR; Pizzorni N; Pirola F; Mengucci A; Dell'Era A; Ottaviani F; Schindler A
J Voice; 2020 Mar; 34(2):280-288. PubMed ID: 30563730
[TBL] [Abstract][Full Text] [Related]
35. Changes in the quality of life of patients with laryngopharyngeal reflux after treatment.
Lee JS; Lee YC; Kim SW; Kwon KH; Eun YG
J Voice; 2014 Jul; 28(4):487-91. PubMed ID: 24598356
[TBL] [Abstract][Full Text] [Related]
36. Predictors of outcome in an open label, therapeutic trial of high-dose omeprazole in laryngitis.
Williams RB; Szczesniak MM; Maclean JC; Brake HM; Cole IE; Cook IJ
Am J Gastroenterol; 2004 May; 99(5):777-85. PubMed ID: 15128336
[TBL] [Abstract][Full Text] [Related]
37. The prevalence of laryngeal pathology in a treatment-seeking population with dysphonia.
Van Houtte E; Van Lierde K; D'Haeseleer E; Claeys S
Laryngoscope; 2010 Feb; 120(2):306-12. PubMed ID: 19957345
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of Laryngopharyngeal Reflux Symptoms, Dysphonia, and Vocal Tract Discomfort in Amateur Choir Singers.
Robotti C; Schindler A; Lechien JR; Di Sabatino A; Capobianco S; Schindler A; Ottaviani F; Sims HS; Bertino G; Benazzo M; Mozzanica F
J Voice; 2023 Nov; 37(6):932-944. PubMed ID: 34404581
[TBL] [Abstract][Full Text] [Related]
39. Change of acoustic parameters before and after treatment in laryngopharyngeal reflux patients.
Jin bJ; Lee YS; Jeong SW; Jeong JH; Lee SH; Tae K
Laryngoscope; 2008 May; 118(5):938-41. PubMed ID: 18520188
[TBL] [Abstract][Full Text] [Related]
40. Vocal allergy: recent advances in understanding the role of allergy in dysphonia.
Roth DF; Ferguson BJ
Curr Opin Otolaryngol Head Neck Surg; 2010 Jun; 18(3):176-81. PubMed ID: 20386448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
